Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
07 avr. 2020 10h53 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has...
Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19
06 avr. 2020 09h25 HE
|
Akers Biosciences Inc.
Successfully obtained clones for all three selected Coronavirus Antigens Thorofare, New Jersey, April 06, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a...
Akers Biosciences, Inc. Provides Notice of Proposed Settlement of Derivative Litigation
17 janv. 2020 17h00 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Jan. 17, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it reached...
Akers Biosciences Appoints Medical Technology Specialist as CEO
23 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of...
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter 2015 Earnings
11 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), (the "Company" or "Akers Bio"), a medical device company focused on reducing the cost of...
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
04 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...